Table 2.

Comparison of cumulative disease activity, treatment, and PT behavior between cases and controls

	Cases, N = 23	Controls, N = 46	p
Disease activity
DAS28	2.2 (1.9–2.6)	2.4 (1.6–2.9)	0.401
Treatment
Number of DMARDs/patient	1.8 (1.2–2)	2.3 (1.6–2.8)	0.003
PT characteristics
% of follow-up with PT	92 (58–100)	67 (47–88)	0.123
Early PTa	17 (73.9)	17 (37)	0.005
PT ≥ 80% of follow-upa	14 (60.9)	17 (37)	0.075

Data presented as median (IQR) and ^anumber (%) of patients